Justin Thacker

Justin Thacker is Capstan’s Chief Financial Officer. Justin brings over 25 years of financial experience, including nearly 15 years in the life sciences industry, to his role. Justin most recently served as Chief Financial Officer at Aristea Therapeutics. Prior to that, he served as Vice President, Finance at Design Therapeutics, Inc., where he played a key role in the company’s $276 million initial public offering. Before that, he was Vice President, Finance, at Synthorx, Inc., where he supported the company’s $150 million initial public offering and finance infrastructure build-out prior to the company’s acquisition by Sanofi. Justin has also held roles at ACADIA Pharmaceuticals Inc., Auspex Pharmaceuticals, Inc. and Cadence Pharmaceuticals, Inc., and supported commercial launches at both ACADIA and Cadence. He began his career with PricewaterhouseCoopers LLP.